Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination
Edtech-HPV
1 other identifier
interventional
672
1 country
4
Brief Summary
This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection. A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2017
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2017
CompletedFirst Submitted
Initial submission to the registry
July 3, 2017
CompletedFirst Posted
Study publicly available on registry
July 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
April 22, 2026
April 1, 2026
9.9 years
July 3, 2017
April 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vaccination completion assessment rate
Comparison rates of vaccination completion will be assessed by Fisher's exact test.
2 years
Study Arms (2)
Parental Education
ACTIVE COMPARATORParticipants will receive parental education on HPV vaccine and the vaccine's benefits.
Parental Education + Text Messaging
EXPERIMENTALParticipants will receive parental education on HPV vaccine and the vaccine's benefits plus text messaging reminder.
Interventions
A one on one twenty-minute parental educational program (in-person or over the phone) providing facts about HPV, HPV-related cancers, and the HPV vaccine.
Participants will receive a text message reminding them of their child's vaccination eligibility once a week, starting one week after participating in the education session (in-person or over the phone). All participants randomized to the text message reminder arm will receive a welcome text message from the automated web-based text messaging service, Mosio, within 72 hours from registration. One week after receiving the welcome text message, they will receive the first weekly text messages reminding them of their child's eligibility for the first dose HPV vaccine. These weekly reminders will occur until uptake of the first dose of the vaccine is reported (through self-report outcome survey completion or submission of the HPV vaccination card/child's official immunization card) or for up to 12 weeks
Eligibility Criteria
You may qualify if:
- Born in Mexico or born in U.S. but self-describes as Mexican-American
- Spanish is his or her primary language
- Has a minimum of one child between the ages of 11 and 17 who has not initiated or completed the HPV vaccine seriest (as per the age-recommended timeframe)
- Self-identifies as the child's main caregiver
- Currently owns a cell phone and uses text messaging services and is willing to accept text messages for this study
- to 84 years old
You may not qualify if:
- Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional's judgment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- Hackensack Meridian Healthcollaborator
Study Sites (4)
Alivio Medical Center
Chicago, Illinois, 60608, United States
Research, Education and Access to Community Health (REACH)
Las Vegas, Nevada, 89101, United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
The University of Texas at El Paso
El Paso, Texas, 79968, United States
Related Publications (1)
Aragones A, Zamore C, Moya EM, Cordero JI, Gany F, Bruno DM. The Impact of Restrictive Policies on Mexican Immigrant Parents and Their Children's Access to Health Care. Health Equity. 2021 Sep 14;5(1):612-618. doi: 10.1089/heq.2020.0111. eCollection 2021.
PMID: 34909528DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Francesca Gany, MD, MS
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2017
First Posted
July 6, 2017
Study Start
June 28, 2017
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
April 22, 2026
Record last verified: 2026-04